Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women

被引:83
|
作者
Van Servellen, G
Chang, B
Garcia, L
Lombardi, E
机构
[1] Univ Calif Los Angeles, Sch Nursing, Acute Care Sect, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90095 USA
关键词
D O I
10.1089/10872910260066705
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Antiretroviral treatment nonadherence is complex, implicating more than a patient's ability and motivation to be compliant. The bulk of the research to date focuses on individual level barriers with less emphasis on the many system level factors that potentially impact patients' adherence behaviors. This study examined the effects of system enabling factors in addition to the frequently studied individual predisposing and enabling factors upon nonadherence to treatment. One hundred eighty-two patients from five community-based clinics were interviewed and their medical charts examined. Patients' self-reported nonadherence was correlated with clinicians' assessments of medication and appointment nonadherence. Seven individual predisposing factors (gender, ethnicity, birthplace, years of education, HIV Overview of Problems-Evaluation System [HOPES] psychosocial, Hospital Anxiety and Depression Scale [HADS] anxiety, and HADS depression scores) were found to be significantly associated with treatment adherence/nonadherence. Individual enabling factors (hopefulness and access to health care), as well as treatment by clinic staff, a system enabling factor, were significantly associated with adherence/nonadherence. In a multivariate analysis, six factors-age (younger), gender (female), birth outside the United States, level of hopefulness (lower), access to health care (lower), and treatment by clinic staff (poorer)-accounted for 19.3% of the variance in nonadherence. Results of this study indicated that several individual predisposing and enabling factors were potential predictors of treatment nonadherence; however, system enabling factors, e. g., treatment by clinic staff were also associated with treatment nonadherence. Further studies are needed to examine the complex relationships of individual and system related factors in predicting treatment nonadherence.
引用
收藏
页码:269 / 281
页数:13
相关论文
共 50 条
  • [31] INCIDENCE OF VENEREAL WARTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED AND UNINFECTED WOMEN
    CHIRGWIN, KD
    FELDMAN, J
    AUGENBRAUN, M
    LANDESMAN, S
    MINKOFF, H
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01): : 235 - 238
  • [32] Invasive and preinvasive cervical neoplasia in human immunodeficiency virus-infected women
    Robinson, W
    SEMINARS IN ONCOLOGY, 2000, 27 (04) : 463 - 470
  • [33] Prevalence of Chlamydia trachomatis in human immunodeficiency virus-infected women in Cuba
    Kouri, V
    Cartaya, J
    Rodríguez, ME
    Muné, M
    Soto, Y
    Resik, S
    Bravo, J
    Llop, A
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (08): : 1073 - 1077
  • [34] Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
    Unadkat, Jashvant D.
    Wara, Diane W.
    Hughes, Michael D.
    Mathias, Anita A.
    Holland, Diane T.
    Paul, Mary E.
    Connor, James
    Huang, Sharon
    Nguyen, Bach-Yen
    Watts, D. Heather
    Mofenson, Lynne M.
    Smith, Elizabeth
    Deutsch, Paul
    Kaiser, Kathleen A.
    Tuomala, Ruth E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 783 - 786
  • [35] Longitudinal analysis of bone density in human immunodeficiency virus-infected women
    Dolan, Sara E.
    Kanter, Jenna R.
    Grinspoon, Steven
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08): : 2938 - 2945
  • [36] CLUES TO ENHANCING THE IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN - REPLY
    STEIN, MD
    ROSENE, KA
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (01): : 160 - 160
  • [37] Hysterosalpingographic evaluation of human immunodeficiency virus-infected and uninfected infertile women
    Onyangunga, Dolongo C.
    Moodley, Jagidesa
    SA JOURNAL OF RADIOLOGY, 2020, 24 (01):
  • [38] PELVIC INFLAMMATORY DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN - REPLY
    KORN, AP
    OBSTETRICS AND GYNECOLOGY, 1994, 83 (03): : 482 - 482
  • [39] Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
    McGowan, JP
    Crane, M
    Wiznia, AA
    Blum, S
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (05): : 641 - 646
  • [40] Prevalence of Anal Dysplasia in Human Immunodeficiency Virus-Infected Transgender Women
    Kobayashi, Takaaki
    Sigel, Keith
    Gaisa, Michael
    SEXUALLY TRANSMITTED DISEASES, 2017, 44 (11) : 714 - 716